(Q37866627)

24 August 2017

1 reference

title

Adaptive immunity in atherosclerosis: mechanisms and future therapeutic targets (English)

1 reference

24 August 2017

1 reference

4

Alain Tedgui

1 reference

24 August 2017

3

Ziad Mallat

1 reference

24 August 2017

Charlotte Lahoute

1

1 reference

24 August 2017

Olivier Herbin

series ordinal

2

1 reference

24 August 2017

language of work or name

English

0 references

publication date

19 April 2011

1 reference

Nature Reviews Cardiology

24 August 2017

published in

1 reference

24 August 2017

volume

8

1 reference

24 August 2017

issue

6

1 reference

24 August 2017

page(s)

348-358

1 reference

Vaccination against atherosclerosis? Induction of atheroprotective immunity

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Contribution of an in vivo oxidized LDL to LDL oxidation and its association with dense LDL subpopulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Human 60-kDa heat shock protein is a target autoantigen of T cells derived from atherosclerotic plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Mapping of vascular dendritic cells in atherosclerotic arteries suggests their involvement in local immune-inflammatory reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Emergence of dendritic cells in rupture-prone regions of vulnerable carotid plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Effect of immune deficiency on lipoproteins and atherosclerosis in male apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Lymphocytes are important in early atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Cytokines in atherosclerosis: pathogenic and regulatory pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Interleukin-17: friend or foe in atherosclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Regulatory T cell responses: potential role in the control of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Peripheral CD4+ T-cell differentiation regulated by networks of cytokines and transcription factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

B-lymphocyte deficiency increases atherosclerosis in LDL receptor-null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Immunoglobulin M is required for protection against atherosclerosis in low-density lipoprotein receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

B cell depletion reduces the development of atherosclerosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Conventional B2 B cell depletion ameliorates whereas its adoptive transfer aggravates atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Cytokines that regulate autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Deficiency of antigen-presenting cell invariant chain reduces atherosclerosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

CD40 and its ligand in atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Reduction of atherosclerosis in mice by inhibition of CD40 signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Requirement for CD154 in the progression of atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

A novel transcription factor, T-bet, directs Th1 lineage commitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Interleukin-18 enhances atherosclerosis in apolipoprotein E(-/-) mice through release of interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

IFN-gamma potentiates atherosclerosis in ApoE knock-out mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Exogenous interferon-gamma enhances atherosclerosis in apolipoprotein E-/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Signal transducer and activator of transcription 1 is required for optimal foam cell formation and atherosclerotic lesion development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Signal transducer and activator of transcription-1 is critical for apoptosis in macrophages subjected to endoplasmic reticulum stress in vitro and in advanced atherosclerotic lesions in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

9p21 DNA variants associated with coronary artery disease impair interferon-γ signalling response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Pathogenesis of allergic airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

T helper-cell phenotype regulates atherosclerosis in mice under conditions of mild hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

IL-33 reduces the development of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Interleukin-4 deficiency decreases atherosclerotic lesion formation in a site-specific manner in female LDL receptor-/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Interleukin-4 does not influence development of hypercholesterolemia or angiotensin II-induced atherosclerotic lesions in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Regulation of immune responses by interleukin-27.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Plasticity of CD4+ T cell lineage differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Interactions among the transcription factors Runx1, RORgammat and Foxp3 regulate the differentiation of interleukin 17-producing T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

A protective function for interleukin 17A in T cell-mediated intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

T-bet represses T(H)17 differentiation by preventing Runx1-mediated activation of the gene encoding RORγt

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Attenuated atherosclerosis upon IL-17R signaling disruption in LDLr deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

IL-17A inhibits the expansion of IL-17A-producing T cells in mice through "short-loop" inhibition via IL-17 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Inhibition of IL-17A attenuates atherosclerotic lesion development in apoE-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

A critical function of Th17 proinflammatory cells in the development of atherosclerotic plaque in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Interleukin-17 and interferon-gamma are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Foxp3+ regulatory T cells: selfishness under scrutiny

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

A function for interleukin 2 in Foxp3-expressing regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

A peripheral CD4+ T cell precursor for naive, memory, and regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Mechanisms of foxp3+ T regulatory cell-mediated suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Regulatory T-cell immunity in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Disruption of T cell homeostasis in mice expressing a T cell-specific dominant negative transforming growth factor beta II receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Disruption of TGF-β signaling in T cells accelerates atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Specific abrogation of transforming growth factor-beta signaling in T cells alters atherosclerotic lesion size and composition in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Low numbers of FOXP3 positive regulatory T cells are present in all developmental stages of human atherosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Atheroprotective effects of Alum are associated with capture of oxidized LDL antigens and activation of regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Impaired regulatory T-cell response and enhanced atherosclerosis in the absence of inducible costimulatory molecule.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Vaccination against Foxp3(+) regulatory T cells aggravates atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Expression of TCTP antisense in CD25(high) regulatory T cells aggravates cuff-injured vascular inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

The role of CD4+CD25+ regulatory T cells in macrophage-derived foam-cell formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Phenotypic and functional switch of macrophages induced by regulatory CD4+CD25+ T cells in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Circulating CD4+CD25hiCD127lo regulatory T-Cell levels do not reflect the extent or severity of carotid and coronary atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Lymphocyte recruitment into the aortic wall before and during development of atherosclerosis is partially L-selectin dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Lymphotoxin beta receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE-/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

The therapeutic potential of targeting B cells and anti-oxLDL antibodies in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Oxidized low-density lipoprotein biomarkers in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Natural antibodies in murine atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Recombinant antibodies to an oxidized low-density lipoprotein epitope induce rapid regression of atherosclerosis in apobec-1(-/-)/low-density lipoprotein receptor(-/-) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Apolipoprotein-mediated lipid antigen presentation in B cells provides a pathway for innate help by NKT cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Evidence for the involvement of T cell costimulation through the B-7/CD28 pathway in atherosclerotic plaques from apolipoprotein E knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Relationships of differential leukocyte and lymphocyte subpopulations with carotid atherosclerosis in elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Regulatory roles for cytokine-producing B cells in infection and autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+ CD27+ CD43+ CD70-

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

The peritoneal cavity provides a protective niche for B1 and conventional B lymphocytes during anti-CD20 immunotherapy in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Disruption of tumor necrosis factor-alpha gene diminishes the development of atherosclerosis in ApoE-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Tumor necrosis factor antagonist mechanisms of action: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Systematic review and meta-analysis: anti-tumor necrosis factor α therapy and cardiovascular events in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Anti-p40 antibodies ustekinumab and briakinumab: blockade of interleukin-12 and interleukin-23 in the treatment of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Genetic analysis of the interleukin-18 system highlights the role of the interleukin-18 gene in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Mucosal administration of heat shock protein-65 decreases atherosclerosis and inflammation in aortic arch of low-density lipoprotein receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Induction of oral tolerance to oxidized low-density lipoprotein ameliorates atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Induction of oral tolerance to HSP60 or an HSP60-peptide activates T cell regulation and reduces atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

In vivo instruction of suppressor commitment in naive T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Oral anti-CD3 antibody treatment induces regulatory T cells and inhibits the development of atherosclerosis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Oral administration of an active form of vitamin D3 (calcitriol) decreases atherosclerosis in mice by inducing regulatory T cells and immature dendritic cells with tolerogenic functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Role of vitamin D in cardiovascular health

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Mechanism of measles virus-induced suppression of inflammatory immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Measles virus nucleoprotein induces a regulatory immune response and reduces atherosclerosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

B-cell targeted therapies in human autoimmune diseases: an updated perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

CD19: a promising B cell target for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Atacicept: targeting B cells in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

B cell receptor and BAFF receptor signaling regulation of B cell homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Crucial role for BAFF-BAFF-R signaling in the survival and maintenance of mature B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Vaccines in development to prevent and treat atherosclerotic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Relationship of anti-60 kDa heat shock protein and anti-cholesterol antibodies to cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Oxidized low-density lipoprotein autoantibodies, chronic infections, and carotid atherosclerosis in a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Immune responses to oxidative neoepitopes on LDL and phospholipids modulate the development of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Evidence for antigen-driven T-cell response in unstable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Identification of immune responses against aldehyde-modified peptide sequences in apoB associated with cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Human dendritic cell subsets for vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Vaccination using oxidized low-density lipoprotein-pulsed dendritic cells reduces atherosclerosis in LDL receptor-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Altered status of CD4(+)CD25(+) regulatory T cells in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Interleukin-18/Interleukin-18 Binding Protein Signaling Modulates Atherosclerotic Lesion Development and Stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Protective Role of Interleukin-10 in Atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Natural regulatory T cells control the development of atherosclerosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Expression of Interleukin-18 in Human Atherosclerotic Plaques and Relation to Plaque Instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Epitope specificity of anti-heat shock protein 65/60 serum antibodies in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Transfer of CD4(+) T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

The role of interleukin 12 in the development of atherosclerosis in ApoE-deficient mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Inhibition of IL-17A in atherosclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Expression of IL-17A in human atherosclerotic lesions is associated with increased inflammation and plaque vulnerability

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

The Th17/Treg functional imbalance during atherogenesis in ApoE(-/-) mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Characterization of Dendritic Cells that Induce Tolerance and T Regulatory 1 Cell Differentiation In Vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Interleukin-10 blocks atherosclerotic events in vitro and in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Role of naturally occurring CD4+ CD25+ regulatory T cells in experimental atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Downregulation of T helper cell type 3 in patients with acute coronary syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

B-Lymphocytes in plaque and adventitia of coronary arteries in two patients with rheumatoid arthritis and coronary atherosclerosis: preliminary observations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Detection of B cells and proinflammatory cytokines in atherosclerotic plaques of hypercholesterolaemic apolipoprotein E knockout mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Distribution of inflammatory cells in adventitia changed with advancing atherosclerosis of human coronary artery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Oral tolerance with heat shock protein 65 attenuates Mycobacterium tuberculosis-induced and high-fat-diet-driven atherosclerotic lesions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Intranasal immunization with an apolipoprotein B-100 fusion protein induces antigen-specific regulatory T cells and reduces atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Short-term treatment with anti-CD3 antibody reduces the development and progression of atherosclerosis in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Prevalence and relation to risk factors of carotid atherosclerosis and left ventricular hypertrophy in systemic lupus erythematosus and antiphospholipid antibody syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

T-cells from advanced atherosclerotic lesions recognize hHSP60 and have a restricted T-cell receptor repertoire.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Relationship between plasma cholesterol, von Willebrand factor concentrations, extent of atherosclerosis and antibody titres to heat shock proteins-60, -65 and -70 in cholesterol-fed rabbits

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Evidence for a role of regulatory T cells in mediating the atheroprotective effect of apolipoprotein B peptide vaccine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.62

Anti-tumor necrosis factor alpha therapy normalizes fibrinolysis impairment in patients with active rheumatoid arthritis

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21502963

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21502963

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Prevalence and relation to risk factors of carotid atherosclerosis and left ventricular hypertrophy in systemic lupus erythematosus and antiphospholipid antibody syndrome

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21502963

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRCARDIO.2011.62

1 reference

24 August 2017

1 reference